Introduction
of leukocytosis and decreasing levels of c-reactive protein.
In Patients 1 and 2 thrombolytic therapy led Immediate treatment of acute portal and mesenteric to the complete recanalisation of the thrombosed veins within 8 days of thrombolysis (Figs 1 and 2) so that vein thrombosis is necessary because of the risk of bowel infarction. Recanalisation of the venous drain-the catheter could be removed. In Patient 3 the treatment had to be discontinued on day 5 due to bleeding age system by transarterial thrombolysis leads to improved venous outflow in the involved bowel from the puncture site in the right groin. At this point the portal vein was completely recanalised while the segments and may prevent the risk of haemorrhagic bowel ischaemia.
superior mesenteric vein remained thrombosed. All three patients were kept on intravenous heparin until coumarin therapy for long-time prevention of thrombotic re-occurrence could be started.
Case Report
Three men, aged between 35 and 61, were admitted Discussion to our hospital with acute onset of abdominal pain and bloody diarrhoea. Colour Doppler ultrasound and Patients with acute portal and mesenteric vein throm-CT scans of the abdomen revealed thrombosis of the bosis are at high risk of developing haemorrhagic portal and superior mesenteric veins in all three bowel infarction due to venous outflow obstruction. patients. A Protein C deficiency could be verified in Different therapeutic options with the aim of the reone of the patients but in the other two no predisposing canalisation of the bowel's venous system have been factors were present. our patients, clinical symptoms diminished within 2 days and the patients were discharged from hospital 3 to 4 weeks later, symptom-free. In Patient 3 thrombolytic treatment had to be discontinued on day 5 due to bleeding from the catheter insertion site in the right groin. At this point the portal vein had recanalised, but the occlusion of the SMV persisted. The fact that he remained asymptomatic may be explained by the development of sufficient collaterals during thrombolysis. None of our patients developed major complications such as acute intestinal bleeding or catheter dislocation, but we believe that such patients should be monitored on the ICU until the treatment is terminated. To our knowledge only three cases of portal and mesenteric vein thrombosis treated with transarterial thrombolysis have been described previously. In all these patients treatment was successful. [3] [4] [5] 
